Charles River Laboratories, Inc

We are seeking a Research Scientist - Molecular Imaging for our Molecular Imaging group in out Mattawan, MI location.. The Molecular Imaging discipline supports small and large molecule drug development through the application of translational, nuclear imaging, quantitative autoradiography and radiopharmaceutical production.. Primary radiopharmaceutical production efforts are focused on development of novel and industry standard automated and manual radiolabeling and production methods to enable in vivo and ex vivo imaging to assess differing parameters of small and large molecules using applicable radioisotopes, such as: 11C, 18F, 64Cu, 68Ga, 89Zr, 99mTc, 111In, 123I, 124I, 125I, 131I, 177Lu, 203Pb, etc.. Utilizing these platforms/assays, the team is for execution of preclinical studies in small and large animal models in both regulated and non regulated preclinical studies.. We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development.

research scientist

For 75 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we'll help you build a career that you can feel passionate about.
Job Summary 
The pay range for this position is $105,000 - $125,000 annually. Please note that salaries vary within the range based on factors including, but not limited to, experience, skills, education, certifications, and location.
We are seeking a Research Scientist - Molecular Imaging for our Molecular Imaging group in out Mattawan, MI location.
The Molecular Imaging discipline supports small and large molecule drug development through the application of translational, nuclear imaging, quantitative autoradiography and radiopharmaceutical production. Primary translational, nuclear imaging platforms and other applicable imaging platforms consist of Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) platforms. Primary radiopharmaceutical production efforts are focused on development of novel and industry standard automated and manual radiolabeling and production methods to enable in vivo and ex vivo imaging to assess differing parameters of small and large molecules using applicable radioisotopes, such as: 11C, 18F, 64Cu, 68Ga, 89Zr, 99mTc, 111In, 123I, 124I, 125I, 131I, 177Lu, 203Pb, etc. Utilizing these platforms/assays, the team is for execution of preclinical studies in small and large animal models in both regulated and non regulated preclinical studies.
Job Qualifications 
Knowledge, Experience, Skills and Abilities required but are not limited to:
<ul>
<li>
Bachelor's degree (BA/BS) with 7-9 years of relevant working experience. Master's degree (MS) with 3-4 years of relevant work experience. Doctorate degree (PhD) with 1-2 years of relevant working experience
</li>
<li>
An equivalent combination of education and experience may be accepted as a satisfactory substitute for the specific education and experience listed above
</li>
<li>
Ability to communicate verbally and in writing at all levels inside and outside the organization
</li>
<li>
Basic familiarity with Microsoft Office Suite
</li>
<li>
Computer skills, commensurate with Essential Functions, including the ability to learn a validated system
</li>
<li>
Ability to work extended hours beyond normal work schedule to include, but not limited to evenings, weekends, extended shifts, and/or extra shifts; sometimes on short notice
</li>
<li>
Ability to work under specific time constraints
</li>
</ul>
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 300 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients' clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 20,000 employees within 110 facilities in over 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client's unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.
At Charles River, we are passionate about our role in improving the quality of people's lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 86% of the drugs approved by the FDA in 2021.
At Charles River Laboratories, we recognize and recruit all talent. We are a company committed to the principle of diversity and inclusion and work daily in this direction.
222623 
<script id="detrack" src="https://d2e48ltfsb5exy.cloudfront.net/p/t.js?i=0,1" data-g="3afc6e04a45949a0b52f01d625f5c26f1624"></script>

START NEW SEARCH